Dr. Duffield is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
401 North Broadway
Pathology, Weinberg Building, Suite 2242
Baltimore, MD 21231Phone+1 410-955-3580- Is this information wrong?
Education & Training
- Johns Hopkins UniversityFellowship, Hematopathology, 2009 - 2010
- Johns Hopkins UniversityResidency, Pathology-Anatomic and Clinical, 2005 - 2009
- Yale School of MedicineClass of 2005
Certifications & Licensure
- NY State Medical License 2020 - 2025
- NJ State Medical License 2021 - 2023
- MD State Medical License 2010 - 2020
- PA State Medical License 2008 - 2010
- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- American Board of Pathology Hematopathology
Publications & Presentations
PubMed
- Regression of smoldering myeloma with treatment of Gaucher disease.Kevin Barley, Anshuman Parekh, Deepa Vatti, Daniel Verina, Violetta V Leshchenko, Sundar Jagannath, Manisha Balwani, Syed Salam, Damodara Rao Mendu, Ravi Prakash Shukl...> ;Blood Advances. 2024 Apr 9
- 3 citationsProgression of follicular lymphoma and related entities: Report from the 2021 SH/EAHP Workshop.Amy S Duffield, Ahmet Dogan, Catalina Amador, James R Cook, Magdalena Czader, John R Goodlad, Reza Nejati, Wenbin Xiao, Lanie Happ, Clay Parker, Elizabeth Thacker, Dev...> ;American Journal of Clinical Pathology. 2023 May 11
- Transdifferentiation, phenotypic infidelity, progression, and transformation in T/NK-cell neoplasms: Report from the 2021 SH/EAHP Workshop.Catalina Amador, James R Cook, Magdalena Czader, Amy Duffield, John Goodlad, Reza Nejati, German Ott, Wenbin Xiao, Sandeep Dave, Mariusz A Wasik, Ahmet Dogan> ;American Journal of Clinical Pathology. 2023 May 11
- Join now to see all
Abstracts/Posters
- The High Mobility Group A1 Chromatin Regulator Is Required for Pathologic Megakaryocyte Development and Progression to Myelofibrosis in JAK2V617F Murine ModelsAmy S. Duffield, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- DOCK2 Expression Affects Leukemogenesis and Disease Progression in a Murine Model of FLT3/ITD Acute Myeloid LeukemiaAmy S. Duffield, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Gilteritinib and Venetoclax Synergize to Eliminate FLT3/ITD+ Leukemia Cells through BIMAmy S. Duffield, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
Press Mentions
- Journal of HematopathologyFebruary 20th, 2019
- Researchers Link Organ Transplant Drug to Rise in Rare LymphomaFebruary 10th, 2016
Hospital Affiliations
- Memorial Sloan Kettering Cancer CenterNew York, New York
- The Mount Sinai HospitalNew York, New York
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/amy-duffield
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: